USMLE® Step 1 & 2

Kaplan USMLE Step 2: 75-year-old with rectal coagulopathy

| 5 Min Read

If you’re preparing for the United States Medical Licensing Examination® (USMLE®) Step 2 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series.

Free study aid when you join the AMA

Medical students who become AMA members can select a free gift from a variety of powerful study aids for the USMLE and COMLEX-USA tests.

Supporting you today as a medical student. Protecting your future as a physician.

A 75-year-old woman with a past medical history significant for paroxysmal atrial fibrillation, hypertension and osteoarthritis comes to the emergency department with bright red blood per rectum. Her medications include warfarin, nifedipine, metoprolol and ibuprofen as needed. She reports that the first incident occurred the previous night, approximately 12 hours earlier, with three subsequent episodes. She denies chest pain, lightheadedness, shortness of breath and abdominal pain. Her temperature is 37.5°C (99.5°F), pulse is 110/minute, respirations are 14/min and blood pressure is 101/72 mm Hg. Abdominal examination is unremarkable, but rectal examination is notable for frank heme-positive stool without palpable masses or hemorrhoids. Laboratory studies show a serum potassium level of 3.1 mEq/L, creatinine 1.4 mg/dL, hemoglobin 6.7 g/dL and INR of 8.5. Which of the following is the best option to reverse her coagulopathy?

A. Activated factor VII

B. Cryoprecipitate

C. Fresh frozen plasma

D. Phytonadione (Vitamin K)

E. Protamine sulfate

 

 

 

 

 

 

 

 

 

 

 

 

The correct answer is C.

Kaplan Medical explains why

Warfarin causes inhibition of the Vitamin K-dependent clotting factors (II, VII, IX, and X, protein C and S). Fresh frozen plasma contains these factors and is the fastest way to reverse coagulopathy caused by warfarin.

Why the other answers are wrong

Choice A. Activated Factor VII has been approved for use in bleeding, but its limited testing and high expense limits its use to critical patients, typically in disseminated intravascular coagulopathy in the operating room.

 

Did you answer the question correctly?

Sign in to get tips to remember and learn more from Kaplan Medical about why the other answer choices can be eliminated.

AMA membership has its advantages

  • Access education programs and study guides to help you thrive.
  • Distinguish yourself with AMA leadership opportunities.
  • Enjoy exclusive perks and savings.

Not a member? Become a member now.

FEATURED STORIES FOR MEDICAL STUDENTS

A square peg forced into a round hole.

This must be the place: Find the right fit in residency interviews

| 5 Min Read
Two figures in a videoconference

To shine in physician residency interviews, showcase 3 key traits

| 4 Min Read
Pen and checklist

Where medical students can stumble in pass-fail preclerkship courses

| 4 Min Read
Upper arm with bandage

Medical students can help change minds on flu vaccination

| 8 Min Read